269
Views
6
CrossRef citations to date
0
Altmetric
Review Article

An overview on the methods of determining the activity of Indoleamine 2, 3-Dioxygenase 1

, , , &
Pages 724-731 | Received 10 Jul 2018, Accepted 05 Sep 2018, Published online: 05 Dec 2018
 

Abstract

Immune escape plays an important hallmark of cancer. The tryptophan-catabolizing enzyme indoleamine 2, 3-dioxygenase 1 (IDO1) is involved in the immune escape mechanism of human tumours, the expression of which is associated with a poor prognosis in cancer and correlated with tumour progression clinically. Therefore, finding the inhibitors targeting IDO1 may be an impellent approach that can reverse the complicated processes in tumour immune escape and induce an antitumor response as well. Here, we summarised and compared some methods of determining the activity of IDO1 and they can be used to screen IDO1 inhibitors as well, including HPLC, fluorescence detection, cell-based assay, NFK GreenScreenTM and absorbance assay. Each determining method possesses special advantages and disadvantages, so we need to have a comprehensive view of these methods and select the most suitable one for further research.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by National Natural Science Foundation of China [Project No. 81773562, No. 81430085, No. 21372206 and No. 81172937 for H.-M.L.]; PhD Educational Award from Ministry of Education [No. 20134101130001, for H.-M.L.]; National Key Research Program of Proteins [No. 2016YFA0501800 for H.-M.L.].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.